Form 3 - Initial statement of beneficial ownership of securities:
SEC Accession No. 0001062993-25-015414
Filing Date
2025-09-08
Accepted
2025-09-08 18:00:59
Documents
2
Period of Report
2025-08-26

Document Format Files

Seq Description Document Type Size
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.html 3  
1 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES form3.xml 3 11946
2 H. TROUT POA exhibit24.txt EX-24 3223
  Complete submission text file 0001062993-25-015414.txt   16605
Mailing Address 4 KINGSBURY AVENUE WATERTOWN MA 02472
Business Address 4 KINGSBURY AVENUE WATERTOWN MA 02472 617 607 0800
ENANTA PHARMACEUTICALS INC (Issuer) CIK: 0001177648 (see all company filings)

EIN.: 043205099 | Fiscal Year End: 0930
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address C/O ENANTA PHARMACEUTICALS, INC. 4 KINGSBURY AVENUE WATERTOWN MA 02472
Business Address
Trout Harry R. III (Reporting) CIK: 0002085123 (see all company filings)

Type: 3 | Act: 34 | File No.: 001-35839 | Film No.: 251301132